Literature DB >> 10715348

The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications.

R E Toohey1, M G Stabin, E E Watson.   

Abstract

Internal dose calculations in nuclear medicine normally use the techniques, equations, and resources provided by the Medical Internal Radiation Dose (MIRD) Committee of the Society of Nuclear Medicine. The MIRD schema uses a unique set of symbols and quantities to calculate the absorbed dose of radiation in any target organ per radioactive decay in any source organ. The calculations involve the energy emitted per radioactive decay, the fraction of the emitted energy that is absorbed in various target organs, the masses of these organs, and both the physical decay and biologic clearance of the injected radioactive material. Standardized mathematical models (phantoms) of the human body and standardized biokinetic models are also used. A computer program, MIRDose, calculates dose tables per unit administered activity of various radiopharmaceuticals. Special care must be taken when nuclear medicine procedures involve pregnant or lactating patients. New methodologies are becoming available to calculate doses to individual patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715348     DOI: 10.1148/radiographics.20.2.g00mc33533

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  12 in total

1.  Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol.

Authors:  Deepa Rani; Sushma Kaisar; Sushma Awasare; Amit Abhyankar; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-01       Impact factor: 9.236

2.  Error evaluation of the D-shuttle dosimeter technique in positron emission tomography study.

Authors:  Md Shahidul Islam; Shoichi Watanuki; Manabu Tashiro; Hiroshi Watabe
Journal:  Radiol Phys Technol       Date:  2019-08-16

Review 3.  Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.

Authors:  Alexander Villalobos; Mohamed M Soliman; Bill S Majdalany; David M Schuster; James Galt; Zachary L Bercu; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

Review 4.  Controversies in the management of Graves' disease in children.

Authors:  S A Rivkees
Journal:  J Endocrinol Invest       Date:  2016-05-06       Impact factor: 4.256

5.  Acute Rodent Tolerability, Toxicity, and Radiation Dosimetry Estimates of the S1P1-Specific Radioligand [11C]CS1P1.

Authors:  Hui Liu; Richard Laforest; Jiwei Gu; Zonghua Luo; Lynne A Jones; Robert J Gropler; Tammie L S Benzinger; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

Review 6.  Therapeutic radionuclides in nuclear medicine: current and future prospects.

Authors:  Chai-Hong Yeong; Mu-hua Cheng; Kwan-Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2014-10       Impact factor: 3.066

Review 7.  Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.

Authors:  Linzi Arndt Webster; Alexander Villalobos; Bill S Majdalany; Zachary L Bercu; Ripal T Gandhi; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

8.  A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.

Authors:  Francesca M Buffa; Glenn D Flux; Matt J Guy; Joe M O'Sullivan; Victor R McCready; Sarah J Chittenden; David P Dearnaley
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-22       Impact factor: 9.236

Review 9.  Targeted Radionuclide Therapy of Human Tumors.

Authors:  Sergey V Gudkov; Natalya Yu Shilyagina; Vladimir A Vodeneev; Andrei V Zvyagin
Journal:  Int J Mol Sci       Date:  2015-12-28       Impact factor: 5.923

Review 10.  Pediatric Graves' disease: management in the post-propylthiouracil Era.

Authors:  Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2014-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.